Immuneering (IMRX) Other Operating Expenses (2022 - 2026)
Immuneering (IMRX) recorded Other Operating Expenses of $20.73 million in Q3 2026, up 90.6% from $10.88 million a year earlier and up 48.0% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Other Operating Expenses (2022 - 2026) Analysis & Trends
On a TTM basis, Immuneering's Other Operating Expenses came in at $54.65 million as of Sep 30, 2026, up 14.6% year-over-year; for FY2025, it came in at $42.08 million, down 12.3% from FY2024.
- Annual Other Operating Expenses has a five-year compound annual growth rate of 22.9% (FY2020 to FY2025).
- Across earlier years, Other Operating Expenses came in at $47.99 million in FY2024 (+15.2%), $41.65 million in FY2023 (+14.8%), $36.3 million in FY2022 (+36.8%) and $26.54 million in FY2021 (+76.9%).
- The Q3 2026 figure is the highest quarterly Other Operating Expenses in data going back to Q2 2020.
- On a year-over-year basis, Other Operating Expenses rose in four of the last eight quarters, with growth averaging 12.7%.
- Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 90.6% in Q3 2026, against a decline of 37.7% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $14 million (Q2 2026), $10.65 million (Q1 2026) and $9.26 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7,317.00 |
| Jun 30, 2026 | 7,317.00 |
| Mar 31, 2026 | 7,317.00 |
| Dec 31, 2025 | 7,317.00 |
| Sep 30, 2025 | 7,317.00 |
| Jun 30, 2025 | 7,317.00 |
| Mar 31, 2025 | 7,317.00 |
| Dec 31, 2024 | 7,317.00 |
| Sep 30, 2024 | 7,317.00 |
| Jun 30, 2024 | 7,317.00 |
| Mar 31, 2024 | 7,317.00 |
| Dec 31, 2023 | 7,317.00 |
| Sep 30, 2023 | 7,317.00 |
| Jun 30, 2023 | 7,317.00 |
| Mar 31, 2023 | 7,317.00 |
| Dec 31, 2022 | 7,316.00 |
| Sep 30, 2022 | 7,317.00 |
| Jun 30, 2022 | 7,317.00 |
| Mar 31, 2022 | 8,103.00 |
API Access
Immuneering Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();